Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
European journal of haematology(2023)
摘要
Although progression is the most common reason for RCT treatment discontinuation in patients with MM, over 10% discontinued due to toxicity. Furthermore, 24.4% of trials showed substantial imbalances between trial cohorts; raising concern for informative censoring and emphasizes the importance of detailed characterization of withdrawal in MM RCTs.
更多查看译文
关键词
multiple myeloma,withdrawal,attrition,systematic review,trials
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要